0001214659-23-008797.txt : 20230623 0001214659-23-008797.hdr.sgml : 20230623 20230623122838 ACCESSION NUMBER: 0001214659-23-008797 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230621 FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krop Julie CENTRAL INDEX KEY: 0001643127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 231036424 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 marketforms-61961.xml PRIMARY DOCUMENT X0407 4 2023-06-21 0001398733 Aquestive Therapeutics, Inc. AQST 0001643127 Krop Julie C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 true false false false 0 Stock Option (Right to Purchase) 2.02 2023-06-21 4 A false 25000 0 A 2024-06-21 2033-06-21 Common Stock 25000 25000 D The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date. /s/ Lori Braender, as Attorney-In-Fact 2023-06-23